Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 96.18M | $ 84.86M | 88.23% |
3/31/2025 | $ 137.65M | $ 85.95M | 62.44% |
12/31/2024 | $ 179.84M | $ 86.04M | 47.84% |
9/30/2024 | $ 234.38M | $ 62.6M | 26.71% |
6/30/2024 | $ 253.8M | $ 63.31M | 24.95% |
3/31/2024 | $ 267.83M | $ 63.99M | 23.89% |
12/31/2023 | $ 173.01M | $ 64.63M | 37.35% |
9/30/2023 | $ 196.77M | $ 65.2M | 33.14% |
6/30/2023 | $ 241.43M | $ 65.76M | 27.24% |
3/31/2023 | $ 275.58M | $ 71.35M | 25.89% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Debt [ $ 26.75M ] / Assets [ $ 507.71M ]
(=) Debt to Assets [ 5.27% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |